Frontline Ltd.
Frontline Ltd.’s preliminary fourth quarter 2020 results will be released on Friday February 19 2020, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call.
In order to attend the conference call you may do one of the following:
a. Webcast
Go to the Investor Relations section at www.frontline.bm and follow the "Webcast" link.
b. Conference Call
Participant dial-in telephone numbers:
Norway | +47 2103 3922 |
Norway toll free | 800 10393 |
UK | +44 (0) 203 009 5709 |
UK Toll Free | 0 800 694 1461 |
USA | +1 646 787 1226 |
USA Toll Free | 866 280 1157 |
Conference ID | 7267424 |
Participants will be asked for their full name & Conference ID.
A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session.
The presentation material which will be used in the teleconference/webcast can be downloaded from www.frontline.bm.
Replay details (available for 7 days)
UK LocalCall | 0 844 571 8951 |
UK FreeCall | 0 808 238 0667 |
Std International | +44 (0) 333 300 9785 |
Norway | 21 03 42 35 |
USA | +1 (917) 677-7532 |
USA Toll Free | +1 (866) 331-1332 |
Conference ID | 7267424 |
Participant information required: Full name & company
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Wolters Kluwer N.V.19.9.2025 08:00:00 CEST | Press release
Wolters Kluwer completes capital reduction
Orion Oyj19.9.2025 08:00:00 CEST | Press release
80,802 Orion Corporation A shares converted into B shares
JDE Peet's N.V.19.9.2025 07:55:00 CEST | Press release
Update on intended recommended public offer by KDP for JDE Peet's
Sampo plc19.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 18 September 2025
Idorsia Pharmaceuticals Ltd19.9.2025 07:00:00 CEST | Press release
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom